Omnix Medical: Funding, Investors & Team (Sep 2026)
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
Omnix Medical has raised $38.1M across 2 funding rounds on record, the most recent a Series C of $25.0M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Omnix Medical Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Omnix Medical Funding Rounds
Omnix Medical raised $13.1M in a Grant announced in Jan 2021.
4.8 years later, a Series C of $25.0M was announced in Oct 2025.
Omnix Medical Founders and Leadership Team
Contact details for the Omnix Medical team: 2 of 2 have an email address on file.
Start 14-day free trial →Omnix Medical Funding Compared to Other Biotechnology Startups
Omnix Medical's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Omnix Medical in Biotechnology and Jerusalem
Companies Similar to Omnix Medical
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Omnix Medical Funding FAQs
What does Omnix Medical do?
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
How much funding has Omnix Medical raised?
Omnix Medical has raised $38.1M across 2 rounds on record. The most recent is a Series C of $25.0M announced in Oct 2025.
When did Omnix Medical last raise funding?
Omnix Medical's most recent funding round on record is a Series C of $25.0M, announced in Oct 2025.
Who founded Omnix Medical?
FundedIQ lists Moshik Cohen Kutner (Founder) at Omnix Medical.
Who is the CEO of Omnix Medical?
Moshik Cohen-Kutner is listed as CEO at Omnix Medical.
Where is Omnix Medical headquartered?
Omnix Medical is based in Jerusalem, Yerushalayim, Israel.
How many employees does Omnix Medical have?
Omnix Medical is in the 11-50 employee band.
How does Omnix Medical's funding compare to other Biotechnology startups?
Omnix Medical's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Omnix Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Omnix Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.